Hallissey M T, Crowson M C, Kiff R S, Kingston R D, Fielding J W
Department of Clinical Studies, Park Hospital, Manchester.
Ann R Coll Surg Engl. 1992 Jan;74(1):59-62.
The use of blood transfusion was examined in 476 patients who underwent curative surgery for large bowel cancer. Of these patients, 128 were not transfused while 348 received a total of 1174 units of blood. A patient was considered over-transfused if the predischarge haemoglobin was more than 12 g/dl. Using this criteria and accepting that single unit transfusions should be avoided, transfusion could have been avoided in 30% of the patients and a total of 377 units were given unnecessarily. Major under-transfusion did not occur; no patient being discharged with a haemoglobin of less than 9 g/dl. This study shows that blood transfusion is overused and the reasons for its use rarely recorded. In view of the morbidity related to transfusion, it is suggested that surgeons and anaesthetists reappraise their transfusion policy and the first step in this must be to record the reason for transfusion.
对476例接受大肠癌根治性手术的患者的输血情况进行了研究。在这些患者中,128例未输血,而348例共接受了1174单位的血液。如果出院前血红蛋白超过12 g/dl,则认为患者输血过量。采用这一标准并假定应避免单次输血,30%的患者本可避免输血,且总共不必要地输注了377单位血液。未发生严重输血不足的情况;没有患者出院时血红蛋白低于9 g/dl。这项研究表明,输血存在过度使用的情况,且使用输血的原因很少被记录。鉴于与输血相关的发病率,建议外科医生和麻醉师重新评估他们的输血政策,而这首先必须记录输血的原因。